Meag Munich Ergo’s Thermo Fisher Scientific TMO Stock Holding History

Meag Munich Ergo’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$15.4M	Sell	38,000 -42,055	-53%	-$17.1M	0.43%	61
2025 Q1	$39.8M	Buy	80,055 +28,474	+55%	+$14.2M	1.17%	41
2024 Q4	$26.8M	Sell	51,581 -14	-0%	-$7.26K	0.85%	52
2024 Q3	$31.9M	Buy	51,595 +969	+2%	+$599K	1%	46
2024 Q2	$28M	Buy	50,626 +26,576	+111%	+$14.7M	0.93%	49
2024 Q1	$14M	Sell	24,050 -568	-2%	-$330K	0.51%	55
2023 Q4	$13.1M	Buy	24,618 +88	+0.4%	+$46.7K	0.5%	60
2023 Q3	$12.4M	Buy	24,530 +47	+0.2%	+$23.8K	0.54%	60
2023 Q2	$12.8M	Sell	24,483 -347	-1%	-$181K	0.56%	60
2023 Q1	$14.3M	Buy	24,830 +7,883	+47%	+$4.54M	0.68%	53
2022 Q4	$9.33M	Buy	16,947 +17	+0.1%	+$9.36K	0.5%	48
2022 Q3	$8.59M	Sell	16,930 -1,699	-9%	-$862K	0.52%	44
2022 Q2	$10.1M	Buy	18,629 +15,169	+438%	+$8.24M	0.6%	37
2022 Q1	$2.07M	Buy	3,460 +3,060	+765%	+$1.83M	0.15%	96
2021 Q4	$267K	Hold	400	–	–	0.02%	167
2021 Q3	$229K	Sell	400 -10,472	-96%	-$6M	0.04%	185
2021 Q2	$5.49M	Buy	+10,872	New	+$5.49M	0.53%	67
2021 Q1	–	Sell	-2,500	Closed	-$1.15M	–	323
2020 Q4	$1.15M	Hold	2,500	–	–	0.27%	111
2020 Q3	$1.1M	Hold	2,500	–	–	0.2%	115
2020 Q2	$906K	Buy	2,500 +1,230	+97%	+$446K	0.17%	125
2020 Q1	$360K	Sell	1,270 -6,178	-83%	-$1.75M	0.09%	137
2019 Q4	$2.42M	Sell	7,448 -20,591	-73%	-$6.69M	0.26%	98
2019 Q3	$8.03M	Buy	28,039 +11,351	+68%	+$3.25M	0.41%	62
2019 Q2	$4.91M	Hold	16,688	–	–	0.38%	63
2019 Q1	$4.51M	Buy	16,688 +15,418	+1,214%	+$4.16M	0.37%	69
2018 Q4	$282K	Sell	1,270 -26,392	-95%	-$5.86M	0.03%	309
2018 Q3	$6.72M	Buy	27,662 +6,529	+31%	+$1.59M	0.4%	74
2018 Q2	$4.38M	Sell	21,133 -37,268	-64%	-$7.73M	0.27%	123
2018 Q1	$12M	Sell	58,401 -1,266	-2%	-$260K	0.49%	51
2017 Q4	$11.5M	Buy	59,667 +43,473	+268%	+$8.36M	0.44%	61
2017 Q3	$3.03M	Buy	+16,194	New	+$3.03M	0.12%	180
2017 Q1	–	Sell	-123,385	Closed	-$17.6M	–	355
2016 Q4	$17.6M	Buy	+123,385	New	+$17.6M	0.82%	31